174 related articles for article (PubMed ID: 24675031)
1. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
Pacheco Dda F; Romero TR; Duarte ID
Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031
[TBL] [Abstract][Full Text] [Related]
2. N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromers.
Yekkirala AS; Lunzer MM; McCurdy CR; Powers MD; Kalyuzhny AE; Roerig SC; Portoghese PS
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5098-103. PubMed ID: 21385944
[TBL] [Abstract][Full Text] [Related]
3. Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox.
Zamora JC; Smith HR; Jennings EM; Chavera TS; Kotipalli V; Jay A; Husbands SM; Disney A; Berg KA; Clarke WP
Pharmacol Res Perspect; 2021 Dec; 9(6):e00887. PubMed ID: 34713624
[TBL] [Abstract][Full Text] [Related]
4. Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene.
Bailey A; Ledent C; Kelly M; Hourani SM; Kitchen I
J Neurosci; 2002 Nov; 22(21):9210-20. PubMed ID: 12417646
[TBL] [Abstract][Full Text] [Related]
5. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series.
Daniels DJ; Lenard NR; Etienne CL; Law PY; Roerig SC; Portoghese PS
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19208-13. PubMed ID: 16365317
[TBL] [Abstract][Full Text] [Related]
6. Opioids differentially modulate two synapses important for pain processing in the amygdala.
Kissiwaa SA; Patel SD; Winters BL; Bagley EE
Br J Pharmacol; 2020 Jan; 177(2):420-431. PubMed ID: 31596498
[TBL] [Abstract][Full Text] [Related]
7. Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm.
Katsuura Y; Taha SA
Neuroscience; 2014 Mar; 261():144-52. PubMed ID: 24342569
[TBL] [Abstract][Full Text] [Related]
8. The Role of Opioid Receptor Antagonists in Regulation of Blood Pressure and T-Cell Activation in Mice Selected for High Analgesia Induced by Swim Stress.
Skiba D; Jaskuła K; Nawrocka A; Poznański P; Łazarczyk M; Szymański Ł; Żera T; Sacharczuk M; Cudnoch-Jędrzejewska A; Gaciong Z
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473865
[TBL] [Abstract][Full Text] [Related]
9. A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
Baamonde A; Menéndez L; González-Rodríguez S; Lastra A; Seitz V; Stein C; Machelska H
Sci Rep; 2020 Oct; 10(1):18599. PubMed ID: 33122720
[TBL] [Abstract][Full Text] [Related]
10. Copaifera langsdorffii Desf. tree oleoresin-induced antinociception recruits µ
Santana VC; Marmentini BM; Cruz GG; de Jesus LC; Walicheski L; Beffa FH; Maffei THP; Streg RV; Veiga-Junior VF; Andrighetti CR; Freitas de Lima MC; de Sousa Valladão DM; de Oliveira RC; Neyra MOC; de Araújo Berber RC; Falconi-Sobrinho LL; Coimbra NC; de Oliveira R
Behav Brain Res; 2024 Mar; 461():114832. PubMed ID: 38142860
[TBL] [Abstract][Full Text] [Related]
11. Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice.
Wang SY; Zhang YZ; Liu XH; Guo XC; Wang XF; Han FT; Zhang Y; Wang CL
Peptides; 2024 Jan; 171():171116. PubMed ID: 37951356
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptors and the discriminative stimulus effects of ethanol in squirrel monkeys: Mu and delta opioid receptor mechanisms.
Platt DM; Bano KM
Eur J Pharmacol; 2011 Jan; 650(1):233-9. PubMed ID: 20940013
[TBL] [Abstract][Full Text] [Related]
13. Tonantzitlolone B Modulates the Endogenous Opioid System to Promote Antinociception in Mice.
do Espírito-Santo RF; Santos DS; Sales Lauria PS; de Lima AA; Abreu LS; Tavares JF; Castilho MS; Pereira Soares MB; Villarreal CF
J Nat Prod; 2023 Nov; 86(11):2514-2521. PubMed ID: 37948340
[TBL] [Abstract][Full Text] [Related]
14. Endogenous opioids suppress activation of nociceptors by sub-nanomolar nicotine.
Miao FJ; Benowitz NL; Levine JD
Br J Pharmacol; 2001 May; 133(1):23-8. PubMed ID: 11325790
[TBL] [Abstract][Full Text] [Related]
15. Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.
Le Naour M; Lunzer MM; Powers MD; Kalyuzhny AE; Benneyworth MA; Thomas MJ; Portoghese PS
J Med Chem; 2014 Aug; 57(15):6383-92. PubMed ID: 24978316
[TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.
Shippenberg TS; LeFevour A; Chefer VI
CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):442-53. PubMed ID: 19128202
[TBL] [Abstract][Full Text] [Related]
17. Genetic and pharmacological antagonism of NK
Sandweiss AJ; McIntosh MI; Moutal A; Davidson-Knapp R; Hu J; Giri AK; Yamamoto T; Hruby VJ; Khanna R; Largent-Milnes TM; Vanderah TW
Mol Psychiatry; 2018 Aug; 23(8):1745-1755. PubMed ID: 28485408
[TBL] [Abstract][Full Text] [Related]
18. Effects of intracerebroventricularly administered opioid peptide antagonists on tissue glycogen levels in rats after exercise.
İlhan AŞ; Güney Ş; Dincer S
Turk J Med Sci; 2021 Aug; 51(4):2185-2192. PubMed ID: 33862670
[TBL] [Abstract][Full Text] [Related]
19. µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice.
Nisbett KE; Vendruscolo LF; Koob GF
Transl Psychiatry; 2024 Feb; 14(1):125. PubMed ID: 38413576
[TBL] [Abstract][Full Text] [Related]
20. Effects of amniotic fluid on opioid activity and fetal responses to chemosensory stimuli.
Korthank AJ; Robinson SR
Dev Psychobiol; 1998 Nov; 33(3):235-48. PubMed ID: 9810474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
